EMBO Reports
EMBO reports
SEARCH Go
My AccountSubmit manuscriptSubscribeRegisterHelp
Journal home
Press releases
Aims and scope
Authors and referees
 Guide for authors
 Guide for referees
 Contact editors
 Advisors & Advisory
 Editorial Board
 Submit a Manuscript
Customer Services
 Subscriptions
 Order sample copy
 Purchase articles
 Reprints and
  permissions
 Contact NPG
 Advertising
EMBO
EMBO
www.embo.org

go to prev issue previous - ISSUE - next go to next issue
EMBO Reports Journal Cover

Contents: Volume 5,
Number 8
 
go to editorial
go to science & society
go to reviews
go to scientific reports
Sign up for eTOCs
Sign upReceive this page by email each issue
editorial
Then and now.

Frank Gannon

EMBO reports 5, 8, 741 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400214
science and society
viewpoint top go to top
A national effort.  Recent developments in Canadian biomedical and health research support

John J. M. Bergeron & Sean C. Taylor

EMBO reports 5, 8, 742–746 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400212
interview top go to top
Science without frontiers.  An interview with Torsten Wiesel, Nobel Laureate and Secretary General of the Human Frontier Science Program

EMBO reports 5, 8, 747–750 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400215
analyses top go to top
The power of giving.  The willingness of philanthropies to venture into neglected areas of scientific research is just one of several advantages to private funding

Caroline Hadley

EMBO reports 5, 8, 751–754 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400213
Finding my enemy's enemies.  The use of friendly microbes to thwart pathogens has a long history. Will the latest wave of discoveries bring us any closer to new biological medicines?

Andrew Moore

EMBO reports 5, 8, 754–757 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400216
When the immune system goes on the attack.  Thanks to advances in research, it may soon be easier to diagnose autoimmune diseases earlier, but therapy remains a tricky problem

Vicki Brower

EMBO reports 5, 8, 757–760 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400217
book review top go to top
From statistics to knowledge.

M. G. Myriam Hunink

EMBO reports 5, 8, 761 (2004). | Full Text | PDF |
doi:10.1038/sj.embor.7400211
reviews
meeting reports top go to top
What's new about RNAi?  Meeting on siRNAs and miRNAs

René F. Ketting & Ronald H.A. Plasterk

EMBO reports 5, 8, 762–765 (2004). | Full Text | PDF |
Published online: 23 July 2004 | doi:10.1038/sj.embor.7400207
The manipulation of immunity.  Conference on From Allergy to Cancer: New Perspectives for Therapeutic Vaccination

Harald von Boehmer & Michel C. Nussenzweig

EMBO reports 5, 8, 766–771 (2004). | Full Text | PDF |
Published online: 16 July 2004 | doi:10.1038/sj.embor.7400204
reviews top go to top
ATM and ataxia telangiectasia.  Second in Molecular Medicine Review Series

Peter J. McKinnon

EMBO reports 5, 8, 772–776 (2004). | Abstract | Full Text | PDF |
doi:10.1038/sj.embor.7400210
The complex life of simple sphingolipids.

Anthony H. Futerman & Yusuf A. Hannun

EMBO reports 5, 8, 777–782 (2004). | Abstract | Full Text | PDF |
doi:10.1038/sj.embor.7400208
scientific reports
Crystal structure of human otubain 2.

Max H Nanao, Sergey O Tcherniuk, Jadwiga Chroboczek, Otto Dideberg, Andréa Dessen & Maxim Y Balakirev

EMBO reports 5, 8, 783–788 (2004). | Abstract | Full Text | PDF | Supplementary Information |
Published online: 16 July 2004 | doi:10.1038/sj.embor.7400201
Dynamic movement of actin-like proteins within bacterial cells.

Hervé Joël Defeu Soufo & Peter L Graumann

EMBO reports 5, 8, 789–794 (2004). | Abstract | Full Text | PDF | Supplementary Information |
Published online: 23 July 2004 | doi:10.1038/sj.embor.7400209
Helicase-dependent isothermal DNA amplification.

Myriam Vincent, Yan Xu & Huimin Kong

EMBO reports 5, 8, 795–800 (2004). | Abstract | Full Text | PDF | Supplementary Information |
Published online: 9 July 2004 | doi:10.1038/sj.embor.7400200
Analysis of developing maize plastids reveals two mRNA stability classes correlating with RNA polymerase type.

A Bruce Cahoon, Faith M Harris & David B Stern

EMBO reports 5, 8, 801–806 (2004). | Abstract | Full Text | PDF |
Published online: 16 July 2004 | doi:10.1038/sj.embor.7400202
Helicase Motif III in SecA is essential for coupling preprotein binding to translocation ATPase.

Efrosyni Papanikou, Spyridoula Karamanou, Catherine Baud, Giorgos Sianidis, Miriam Frank & Anastassios Economou

EMBO reports 5, 8, 807–811 (2004). | Abstract | Full Text | PDF | Supplementary Information |
Published online: 23 July 2004 | doi:10.1038/sj.embor.7400206
UVA inactivates protein tyrosine phosphatases by calpain-mediated degradation.

Pawan Gulati, Boyka Markova, Martin Göttlicher, Frank-D Böhmer & Peter A Herrlich

EMBO reports 5, 8, 812–817 (2004). | Abstract | Full Text | PDF | Supplementary Information |
Published online: 9 July 2004 | doi:10.1038/sj.embor.7400190
Shp1 and Ubx2 are adaptors of Cdc48 involved in ubiquitin-dependent protein degradation.

Christian Schuberth, Holger Richly, Sebastian Rumpf & Alexander Buchberger

EMBO reports 5, 8, 818–824 (2004). | Abstract | Full Text | PDF | Supplementary Information |
Published online: 16 July 2004 | doi:10.1038/sj.embor.7400203
HMGB1 is an endogenous immune adjuvant released by necrotic cells.

Patrizia Rovere-Querini, Annalisa Capobianco, Paola Scaffidi, Barbara Valentinis, Federica Catalanotti, Marta Giazzon, Ingrid E Dumitriu, Susanne Müller, Matteo Iannacone, Catia Traversari, Marco E Bianchi & Angelo A Manfredi

EMBO reports 5, 8, 825–830 (2004). | Abstract | Full Text | PDF |
Published online: 23 July 2004 | doi:10.1038/sj.embor.7400205
top go to top
Privacy PolicyCopyright © 2004 by the European Molecular Biology Organization